[Clinical studies of cefditoren pivoxil in pediatric field].

Author: AokiS, NishimuraT, TabukiK, TakagiM

Paper Details 
Original Abstract of the Article :
We have carried out clinical studies on cefditoren pivoxil (CDTR-PI, ME1207) in granules. The results are summarized as follows. Treatment with CDTR-PI was made for 14 cases of pediatric bacterial infections: 4 cases of tonsillitis, 2 cases of pneumonia, 3 cases of scarlet fever, 3 cases of impetigo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/8371497

データ提供:米国国立医学図書館(NLM)

Cefditoren Pivoxil: A Promising Option for Pediatric Bacterial Infections

The treatment of [bacterial infections] in children is a delicate matter, requiring effective and safe medications. This study explores the effectiveness of [cefditoren pivoxil], a new antibiotic, in treating a range of bacterial infections in children.

The study included [14 pediatric patients] with a variety of bacterial infections, demonstrating the effectiveness of cefditoren pivoxil in treating these infections. Importantly, the study noted [no significant side effects], suggesting that cefditoren pivoxil may be a well-tolerated option for children.

Expanding the Treatment Options for Children

The study's findings suggest that cefditoren pivoxil could be a valuable addition to the treatment options for [pediatric bacterial infections]. Its efficacy and favorable safety profile make it a promising alternative for clinicians seeking to manage these common infections in children.

Protecting Children's Health: A Collective Responsibility

As a researcher, I am always heartened by studies that offer promising solutions for children's health. This study reminds us that ensuring the well-being of our youngest members is a shared responsibility. Let's continue to support research that develops innovative and safe treatments for our children.

Dr. Camel's Conclusion

This study provides valuable insights into the potential of cefditoren pivoxil as a treatment for various bacterial infections in children. The positive outcomes observed in this small study warrant further investigation to confirm its efficacy and safety in larger populations.

Date :
  1. Date Completed 1993-10-08
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

8371497

DOI: Digital Object Identifier

8371497

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.